Virogin Biotech was founded in 2015, with a vision to be a global, best-in-class oncolytic virus company that creates impactful drugs for patients of highest medical need. We are a company with over 100 employees and R&D facilities in Vancouver, Canada and Shanghai, China.
At Virogin, we are at the forefront of developing novel oncolytic virotherapies. For every decision we make in the workplace, we think of the patients first. Virogin aims to be a Global, best-in-class oncolytic virus company that creates impactful drugs for patients of the highest medical need.
In 2019, Virogin and CNBG established a joint venture in Shanghai Nanxiang Biotech Campus. The entity is dedicated to clinical development, clinical operations, and manufacture deliveries for the global clinical market in North America, Australian, and China.
The company provides exciting and promising opportunities for experienced candidate and graduates. Scientific experts and business professionals, if you are highly motivated and passionate in curing cancers, improving human well-beings, sharing our mission of bring the best-in-class medicine to patients, please send us your application. Our Core Values are: Teamwork, Integrity, Creativity, Dedication, Reliability.